The Drugs Controller of India has intensified regulatory oversight against the unauthorized sale and promotion of GLP-1-based weight loss drugs. This move comes amid growing concerns over the increasing availability of multiple generic versions of these drugs in the Indian market, through retail...
adverse effects
cardiologists
drug promotion
drug sales
drugs controller of india
endocrinologists
glp-1 drugs
healthcare regulation
india
internal medicine specialists
medical supervision
pharmaceutical supply chain
prescription drugs
regulatory oversight
weightlossdrugs
New Delhi, February 17 The apex drug regulator, CDSCO, has approved three drugs – Orlistat, Tirzepatide, and Semaglutide – for weight loss treatment in the country, which can be sold in retail with a doctor's prescription, Minister of State for Health, Anupriya Patel, said on Tuesday.All drugs...